Company Overview of Canaccord Genuity Inc.
Canaccord Genuity Inc. is an investment banking firm that provides financial advisory services. The firm offers mergers and acquisitions advisory, divestitures, recapitalizations, valuations, fairness opinions, private placements, private capital raising, and valuation analysis services. Additionally, it provides underwriting, Initial Public Offering (IPO), and equity sales and trading services. The firm caters to metals and mining, energy, technology, telecommunications, life sciences, real estate, and aerospace industries. Canaccord Adams, formerly known as Adams Harkness, Inc., was founded in 1969 and is based in Boston, Massachusetts with additional offices across the United States. Cana...
99 High Street
Boston, MA 02110
Founded in 1969
Key Executives for Canaccord Genuity Inc.
Chief Financial Officer and Treasurer
Managing Director of Capital Markets
Compensation as of Fiscal Year 2015.
Canaccord Genuity Inc. Key Developments
Muscle Pharm To Sell Stakes In BioZone Laboratories
Nov 17 15
Muscle Pharm Corp. (OTCPK:MSLP) to explore the sale of all or substantially all of the assets of BioZone Laboratories Inc. MusclePharm Corporation announced that it has retained an Genuity Inc. to explore the sale of all or substantially all of the assets of its BioZone Laboratories Inc. Ryan Drexler, Executive Chairman of Muscle Pharm, said, “We remain committed to acting in the best interests of our shareholders and further maximizing shareholder value. At the end of the day, we are a sales and marketing company, and that is where we want to focus. As a result, we are going to concentrate on our core competencies while leaving other aspects of the business to strategic partners or outside parties who can bring more expertise to those areas than us. As part of this process, MusclePharm has retained investment bank Canaccord Genuity Inc. to advise the Board of Directors and management with respect to a sale.” The Company said there can be no assurance that its evaluation process will result in any transaction or that any transaction, if pursued, will be consummated.
SynCardia Hires Canaccord To Consider Strategic Alternatives
Nov 4 15
SynCardia Systems, Inc. has initiated a process to explore and evaluate all potential strategic alternatives to maximize stakeholder value, including a possible sale of the business. Michael Garippa, SynCardia Chief Executive Officer, said "SynCardia develops and manufactures the only FDA and CE Mark Total Artificial Heart, an implantable system designed to assume the full function of a failed human heart in patients suffering from advanced heart failure. The SynCardia Board of Directors has retained Canaccord Genuity to evaluate and identify strategic alternatives aimed at optimizing the value of our business and technology, which have resulted in over 1,500 implants of our Total Artificial Heart in patients globally.” Conaccord Genuity Inc. has been hired by SynCardia to explore and evaluate all potential strategic alternatives.
Canaccord Genuity Appoints Blake Tennant as Managing Director, Industrials and Infrastructure Services
Oct 21 15
Canaccord Genuity announced that Blake Tennant has joined its investment banking team as Managing Director, Industrials and Infrastructure Services. Mr. Tennant will be based in Washington, DC and will focus on leveraging Canaccord Genuity's global capabilities to deliver a broad range of investment banking services, including public offerings, private placements, and mergers and acquisitions advisory services. Mr. Tennant joins Canaccord Genuity from FBR Capital Markets, where he spent the past 9 years, most recently as a Managing Director, and Head of Infrastructure Investment Banking.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|